Docosahexaenoic Acid and Eicosapentaenoic Acid: study protocols
7 study groups took Docosahexaenoic Acid together with Eicosapentaenoic Acid. These are the doses the studies gave. They are not a recommendation.
Dose per serving from research: Docosahexaenoic Acid
7 study groups in 5 studies say how much Docosahexaenoic Acid participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 100 mg to 250 mg, 43% of 7 study groups.
| Daily dose | Study groups |
|---|---|
| 100 mg to 250 mg | 3 |
| 250 mg to 500 mg | 2 |
| 500 mg to 1 g | 1 |
| 1 g to 2.5 g | 1 |
Dose per serving from research: Eicosapentaenoic Acid
6 study groups in 4 studies say how much Eicosapentaenoic Acid participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 100 mg to 250 mg, 67% of 6 study groups.
| Daily dose | Study groups |
|---|---|
| 100 mg or less | 1 |
| 100 mg to 250 mg | 4 |
| 250 mg to 500 mg | 1 |
Commonly used together
5 of 7 study groups took Docosahexaenoic Acid and Eicosapentaenoic Acid with something else. Shown: what 3 or more different studies gave.
What was given together, not what works together.
| Taken with | Study groups |
|---|---|
| Fish Oil | 4 |
7 study groups
| Study | ||||
|---|---|---|---|---|
| Short-Term Omega 3 Fatty Acids Treatment for Dry Eye in Young and Middle-Aged Visual Display Terminal Users 2016 · O3FA group · Young and middle-aged visual display terminal users with dry eye symptoms | 240 mg | 360 mg | 45 days | 256 |
| Effect of n-3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial 2012 · n-3 LCPUFA group · Pregnant women from Adelaide whose unborn baby had a mother, father, or sibling with a history of medically diagnosed allergic disease | 800 mg | 100 mg | — | 368 |
| Effect of omega-3 fatty acids on kidney function after myocardial infarction: the Alpha Omega Trial 2014 · eicosapentaenoic acid-docosahexaenoic acid group · Patients aged 60–80 years with a history of myocardial infarction; 81% were men. | 159 mg | 239 mg | 1200 days | — |
| Prevention of Potential Adverse Metabolic Effects of a Supplementation with Omega-3 Fatty Acids Using a Genetic Score Approach 2020 · n-3 PUFA supplementation · Adults; age, sex, and health condition not specified | 1.1 g | — | 6 weeks | 210 |
| Decreased cord blood IL-4, IL-13, and CCR4 and increased TGF-beta levels after fish oil supplementation of pregnant women 2008 · fish oil (FO) · pregnant women; age and health condition not specified | 500 mg | 150 mg | — | — |
| Effect of omega-3 fatty acids on kidney function after myocardial infarction: the Alpha Omega Trial 2014 · eicosapentaenoic acid-docosahexaenoic acid plus α-linolenic acid group · Patients aged 60–80 years with a history of myocardial infarction; 81% were men. | 159 mg | 239 mg | 1200 days | — |
| Decreased cord blood IL-4, IL-13, and CCR4 and increased TGF-beta levels after fish oil supplementation of pregnant women 2008 · fish oil (FO) and methyl-tetra-hydrofolic acid · pregnant women; age and health condition not specified | 500 mg | 150 mg | — | — |